SAN DIEGO, CA, Dec. 30, 2025 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL) ("RYVYL” or the "Company”) today announced that ...

Rithm Property Trust Inc. (NYSE: RPT, "RPT" or the "Company") today announced that its Board of Directors unanimously ...

The Reverse Stock Split was approved by the Company's stockholders at the Company's Annual Meeting of Stockholders held on July 24, 2025 (the "Annual Meeting") to be effected in the Board's discretion ...

Robin Energy Ltd. (NASDAQ: RBNE) ("Robin Energy" or the "Company"), an international ship-owning company providing energy transportation services globally, today announces that its board of directors ...

At the Special Meeting of Stockholders held on December 5, 2025, the Company's stockholders approved a reverse stock split of ...

Buffalo Potash Corporation (formerly 1377319 B.C. Ltd.) (“Buffalo Potash” or the “Company”) is pleased to announce that it ...

Forbes contributors publish independent expert analyses and insights. Kris Holt is a writer who covers video games and word games. Hey there, Connectors! The weekend is almost here. But wait! Don’t ...

Common Stock to Begin Trading on Reverse-Split Adjusted Basis on January 2, 2026 SAN DIEGO, CA, Dec. 30, 2025 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL) ("RYVYL" or the "Company") today announced ...

VisionSys AI Inc (NASDAQ: VSA), today announced that it will effect a reverse share split of its outstanding ordinary shares, par value $0.00002 per share (the “Ordinary Shares”), and its American ...

The Company is undertaking the Reverse Stock Split with the objective of meeting the minimum $1.00 per Ordinary Share bid requirement for maintaining the listing of the Ordinary Shares on The Nasdaq ...

Split Adjusted Basis on December 23, 2025 DULUTH, Ga.--(BUSINESS WIRE)--Boxlight Corporation (Nasdaq: BOXL), a leading provider of interactive technology solutions, today announced that its ...

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases ...